Coronary Artery Disease
Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non–insulin-dependent diabetes mellitus

https://doi.org/10.1016/S0002-9149(98)00777-2Get rights and content

Abstract

Microalbuminuria is an increase in urinary albumin not detected by conventional dipstick testing and is present in 20% of patients with non–insulin-dependent diabetes mellitus (NIDDM). Mortality in NIDDM patients with microalbuminuria is 60% at 8 years and is mainly due to cardiovascular disease. Because many deaths occur without warning symptoms, we have compared the prevalence and severity of silent myocardial ischemia in asymptomatic NIDDM patients with and without microalbuminuria. We have performed a cross-sectional, case-control study of asymptomatic NIDDM patients attending hospital diabetes clinics. Forty-three patients with microalbuminuria were matched for age, gender, diabetes duration, and smoking status with 43 normoalbuminuric patients. A symptom-limited exercise stress test was performed and reported blind to patient status. The degree of electrocardiographic ST-segment depression, exercise time, work performed, and maximum heart rate with exercise were recorded. Patients with microalbuminuria had a higher prevalence of ischemic response (>1 mm ST depression) (65% vs 40%, p = 0.016), reduced total exercise time (5 vs 7 minutes, p <0.001), reduced work (6 vs 8 METs, p<0.001), and reduced age-predicted maximum heart rate (94% vs 101%, p = 0.004). In multiple logistic regression, albumin excretion rate was shown to be the strongest independent predictor of ischemic response (p = 0.03). Silent myocardial ischemia is common in asymptomatic NIDDM patients but is more common in those with microalbuminuria. In these subjects, the higher prevalence of ischemic response at low workloads suggests a higher probability of future coronary events, and possibly a higher probability of potentially treatable coronary artery disease.

Section snippets

Patient selection

NIDDM patients (according to World Health Organization criteria), aged 45 to 75 years, were recruited from hospital diabetic clinics in Newcastle upon Tyne, United Kingdom. Exclusion criteria were: NIDDM for <1 year, history of myocardial infarction, history of angina, as defined by the Rose questionnaire,12 heart failure, uncontrolled hypertension (blood pressure >180/100 mm Hg), significant aortic stenosis, cardiomyopathy, known serious arrhythmias, left bundle branch block, previous coronary

Clinical and biochemical characteristics

The success of the matching was demonstrated by no significant differences in age, gender, known diabetes duration, or smoking status between groups (Table I). Clinical assessment showed that patients with microalbuminuria were more likely to have symptoms of intermittent claudication, peripheral neuropathy, and a history of higher alcohol intake than those with normoalbuminuria. Those with microalbuminuria also had increased body mass index, waist hip ratio, systolic blood pressure, and

Discussion

We have shown that silent myocardial ischemia is common in asymptomatic NIDDM patients both with (65%) and without microalbuminuria (40%), but in those with microalbuminuria, it is more common and occurs at lower workloads. We have demonstrated that in asymptomatic NIDDM patients, the presence of microalbuminuria is the strongest independent predictor of ischemic response on treadmill exercise testing.

References (27)

  • W.J Rogers et al.

    Asymptomatic Cardiac Ischemia Pilot (ACIP) studyoutcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators

    J Am Coll Cardiol

    (1995)
  • W.B Kannel et al.

    Diabetes and cardiovascular disease. The Framingham study

    JAMA

    (1979)
  • P.F Cohn

    Silent Myocardial Ischemia and Infarction

    (1993)
  • Cited by (80)

    • Screening for the Presence of Cardiovascular Disease

      2018, Canadian Journal of Diabetes
      Citation Excerpt :

      Myocardial ischemia (whether silent or symptomatic) detected during exercise stress testing in individuals with diabetes is associated with poorer long-term survival compared to individuals without diabetes (16). Silent MI is common (40%) in older asymptomatic individuals with type 2 diabetes, but is more frequent (65%) in those with diabetes who also have microalbuminuria (35). People with diabetes and silent ischemia have an annual event rate for CAD of 6.2% (50% of events were new-onset angina and 50% were cardiac death or MIs) (36).

    • Cardiovascular disease in diabetes

      2018, Encyclopedia of Endocrine Diseases
    • Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus

      2017, International Journal of Cardiology
      Citation Excerpt :

      The predictive role of an increased BNP-value at baseline is in line with results of a primary prevention study in which BNP was used to identify end organ damage of the heart: in asymptomatic primary prevention patients, BNP screening was able to identify silent heart disease [17]. On the other side and in contrast to several other studies [18,19], neither an increased creatinine level nor the presence of microalbuminuria were independently predictive of an abnormal MPS in the present analysis. This may be explained partly by the frequent use of ACE-/ARB-inhibitors (77%), the highly selected patient group tested and the multiple predictors analysed in the current versus older studies [15,18].

    • Chest Pain

      2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth Edition
    • Dépistage de la coronaropathie

      2013, Canadian Journal of Diabetes
      Citation Excerpt :

      Chez les personnes diabétiques, une ischémie myocardique (silencieuse ou symptomatique) décelée pendant une épreuve d’effort est associée à une moindre survie à long terme, comparativement à celle observée chez les personnes non diabétiques (7). Une ischémie myocardique (IM) silencieuse est courante (40 %) chez les personnes plus âgées souffrant de diabète de type 2, mais elle est plus fréquente (65 %) chez les personnes diabétiques présentant également une microalbuminurie (19). Les personnes souffrant de diabète et d’ischémie silencieuse présentent un taux annuel d’événements coronariens de 6,2 % (dans la moitié [50 %] des cas, il s’agissait d’une angine d’apparition nouvelle, et dans l’autre moitié [50 %], d’un décès d’origine cardiaque ou d’une IM) (20).

    View all citing articles on Scopus

    This study was supported by grants from The Northern Region Small Grants Committee, The Freeman Hospital Board of Trustees, Newcastle upon Tyne, United Kingdom; Novo Nordisk, Crawley, West Sussex; Bayer plc, Newbury, Berkshire; and Eli Lilly and Co. Ltd., Basingstoke, Hampshire, United Kingdom.

    View full text